Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 4,697 | 19,990 | 18,333 | 18,665 | 16,108 |
| Cost of Goods | 533 | 7,120 | 7,164 | 10,772 | 11,047 |
| Gross Profit | 4,164 | 12,860 | 7,386 | 7,893 | 5,061 |
| Operating Expenses | 6,445 | 10,500 | 164 | 15,717 | 13,828 |
| Operating Income | -1,749 | 2,490 | 11,169 | -7,052 | -8,720 |
| Interest Expense | 585 | 800 | 1,053 | 1,223 | 446 |
| Other Income | 197 | 200 | -10,799 | -1,103 | -192 |
| Pre-tax Income | -2,138 | 1,890 | -683 | -9,378 | -9,358 |
| Net Income Continuous | -2,138 | 1,896 | -968 | -9,378 | -9,359 |
| Net Income Discontinuous | 4,510 | 0 | 0 | 0 | 0 |
| Net Income | $2,372 | $1,890 | $-968 | $-9,378 | $-9,358 |
| EPS Basic Total Ops | 9.60 | 8.00 | -3.20 | -41.60 | -45.60 |
| EPS Basic Continuous Ops | -8.80 | 8.00 | -3.20 | -41.72 | -45.50 |
| EPS Basic Discontinuous Ops | 17.97 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 9.60 | 7.20 | -3.20 | -41.60 | -45.60 |
| EPS Diluted Continuous Ops | -8.80 | 7.20 | -3.20 | -41.72 | -45.50 |
| EPS Diluted Discontinuous Ops | 17.82 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,500 | $3,850 | $11,169 | $-5,658 | $-7,342 |